Equity Research, Broker Reports, and media content on ValiRx PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ValiRx PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

ValiRx PLC

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ValiRx PLC. We currently have 122 research reports from 8 professional analysts.

  • Open: 16.2p
  • Range Today: 15.6/16.2p
  • 52 Week: 10.0/65.0p
  • Daily Volume: 150.9k
  • Daily Liquidity: 0.17%
  • # Shares: 90.2m
  • Market Cap: £14.4m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
22Sep22 07:00 RNS ValiRx PLC - Live Shareholder Q&A and industry events
08Sep22 07:00 RNS ValiRx PLC - Appointment of Interim Chief Scientific Officer
06Sep22 07:15 RNS ValiRx PLC - Proposed Appointment of Non-Executive Director
06Sep22 07:00 RNS ValiRx PLC - Issue of Share Options
31Aug22 07:00 RNS ValiRx PLC - Half-year Report
17Aug22 07:00 RNS ValiRx PLC - Shareholder Communications
14Jul22 10:46 RNS ValiRx PLC - Holding(s) in Company
  • Frequency of research reports


  • Research reports on

    ValiRx PLC

  • Providers covering

    ValiRx PLC

ValiRx PLC is a life science company with a focus on clinical-stage drug development. The company trades under the ticker Lon:VAL